Isis Pharmaceuticals Financial Statements
Isis Pharmaceuticals Financial Information
| Company Type | Public Headquarters |
|---|---|
| Fiscal Year-End | December |
© 2009 Morningstar, Inc. Financial Data provided by
Isis Pharmaceuticals Income Statement
| 2008 | 2007 | 2006 | |
|---|---|---|---|
| Revenue ($ mil.) | 107.2 | 69.6 | 24.5 |
| Gross Profit ($ mil.) | -- | -- | -- |
| Operating Income ($ mil.) | -- | -- | -- |
| Total Net Income ($ mil.) | (12.0) | (136.3) | (68.9) |
| Diluted EPS (Net Income) | (0.13) | (1.63) | (0.62) |
Isis Pharmaceuticals Quarterly Statements
| Quarter Ending Sep 09 | Quarter Ending Jun 09 | Quarter Ending Mar 09 | |
|---|---|---|---|
| Revenue ($ mil.) | 26.8 | 31.0 | 31.6 |
| Gross Profit ($ mil.) | -- | -- | -- |
| Operating Income ($ mil.) | (8.8) | (0.5) | 1.5 |
| Total Net Income ($ mil.) | (8.1) | (3.8) | 170.9 |
| Diluted EPS (Net Income) | (0.07) | (0.03) | 1.57 |
Isis Pharmaceuticals Stock Quote & Chart
11/09/09 16:00:01 EST •
NASDAQ •
13.58
•
 +0.1200
•
+0.8915 %
|
|---|
|
Quotes delayed 15 minutes for NASDAQ. 20 minutes for NYSE and AMEX. Market Data provided by Interactive Data. Powered and Implemented by Interactive Data Managed Solutions.
|
Isis Pharmaceuticals Financial Ratios
| Company | Industry Median |
Market Median1 |
|
|---|---|---|---|
| Price/Sales Ratio | 11.51 | 16.45 | 7.01 |
| Price/Earnings Ratio | (555.56) | 384.62 | 25.51 |
| Price/Book Ratio | 4.34 | 3.53 | 6.74 |
| Price/Cash Flow Ratio | (16.39) | 80.00 | 43.48 |
1 Public companies trading on the New York Stock Exchange, the American Stock Exchange, and the NASDAQ National Market.
Detailed Isis Pharmaceuticals Financial Ratios
Isis Pharmaceuticals Competitive Intelligence
| AVI BioPharma | Enzo Biochem | Genta | |
|---|---|---|---|
| Annual Sales ($ mil.) | 21.3 | 89.6 | 0.4 |
| Employees | 83 | 614 | 25 |
| Market Cap ($ mil.) | 123.4 | 214.3 | 0.5 |
Competitive Landscape
